Just released: The Q2, 2026 Exit Readiness Index. See how ready owners really are to sell. Get the free report →
To read a transcript of this episode, click here.
When we discover a vaccine or reliable treatment regime for COVID-19, there will inevitably be an unscrupulous gang of counterfeiters trying to make a quick buck by selling fake remedies.
Systech International could provide a defence against these crooked operators. Systech has developed technology that allows drug makers to create a unique bar code for each of their products, which stops counterfeiters from ripping them off. The technology is used by drug manufacturers and just about any company that needs to ensure its packaged products are safe and authentic.
In March of 2018, Ara Ohanian was brought into Systech as the CEO and tasked with creating some liquidity for its shareholders, which he did in January 2020, when Dover Corporation (NYSE: DOV) acquired them.
Ohanian described two big strategic moves he made, which should be in every value builder’s playbook:
There are lots of gems in this interview, including:
One of the first things Ohanian did when he took over Systech was to identify new growth markets for his technology, which led him to Dover. If you’re curious to find new markets for your existing products and services, we’ll take you through Your Growth Quad exercise in Module 4 of The Value Builder System™. Get started now by completing module 1 for free.
Ara is a Seasoned B2B enterprise CEO and entrepreneur who has run software businesses from startups to $300M in revenue. His successful exits include selling Certpoint Systems to Infor, a $4B ERP player; and most recently the sale of Systech International to Dover Corp, a $9B public company. Ara ‘s tenure also includes 4 years as SVP and GM of Infor’s statutory compliance business. His expertise spans building global operations, developing multi-industry distribution channels and delivering robust growth and profitability. In addition to running companies, Ara teaches as an Adjunct Professor at City University of NY, and as the entrepreneur-in-residence at NY Institute of Technology’s center for entrepreneurship.